Weill Cornell Medical College in Qatar-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2015

  1. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer

    Breast Cancer Research, Vol. 17, Núm. 1

2014

  1. Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Núm. 24, pp. 8838-8843